A Study of Tarlatamab for People With Prostate Cancer
Clinical trial NCT07111507 · RECRUITING
Trial details
- NCT number
- NCT07111507
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-31
- Primary completion
- 2027-08-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.